ArticleInterventional pain medicine2026
Basivertebral nerve ablation provides comparable early pain relief in patients with psychiatric conditions: A real-world study.
Article in Interventional pain medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Patients with psychiatric conditions experience higher rates of chronic low back pain (LBP) compared to the general population and frequently face worse outcomes, including delayed diagnosis, higher rates of opioid dependence, and suboptimal pain management. Despite the high burden of chronic LBP on patients with psychiatric illnesses, the effectiveness of interventional pain management procedures in this population remains understudied. Objective: This study sought to evaluate early pain reduction and functional outcomes following BVN ablation in patients with psychiatric conditions. Methods: A retrospective chart review was conducted on patients who underwent BVN ablation at our institution from November 2019 to January 2025. For patient group designation and comparison, we identified Patients with Psychiatric Conditions (PCC, N = 52) and Patients without Psychiatric Conditions (Non-PPC, N = 82). Psychiatric diagnoses included anxiety disorders, major depressive disorder, bipolar disorder, Tourette's syndrome, and substance use disorders. Pain severity was assessed using the Visual Analog Scale (VAS) at baseline and at the 4-6-week post-procedure follow-up visit, and functional improvement was determined based on documented patient-reported outcomes at the same time point. Results: A statistically significant decrease in VAS was observed in the PPC cohort (7.4 vs. 3.71, p = 0.006) and the Non-PPC cohort (6.82 vs. 3.82, p = 0.017). When comparing the PPC cohort to the Non-PPC cohort, no statistically significant difference was observed in the percentage of patients reporting improvement in functional status after the procedure (80.8% vs. 78.0%, p = 0.706). Conclusions: At 4-6-weeks post procedure, patients with psychiatric conditions experienced significant pain relief and improvement in functional status comparable to patients without psychiatric conditions. These findings suggest that having a documented psychiatric condition does not significantly alter early pain relief or functional improvement outcomes after BVN ablation.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.